Global Ivosidenib Market Growth 2022-2028
- LP 4871652
- 70 Pages
- February 2022
- Pharmaceuticals
The United States Ivosidenib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ivosidenib market, reaching US$ million by the year 2028. As for the Europe Ivosidenib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ivosidenib players cover Agios Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ivosidenib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
60 Tablets
30 Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Agios Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ivosidenib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ivosidenib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ivosidenib by Country/Region, 2017, 2022 & 2028
2.2 Ivosidenib Segment by Type
2.2.1 60 Tablets
2.2.2 30 Tablets
2.3 Ivosidenib Sales by Type
2.3.1 Global Ivosidenib Sales Market Share by Type (2017-2022)
2.3.2 Global Ivosidenib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ivosidenib Sale Price by Type (2017-2022)
2.4 Ivosidenib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Ivosidenib Sales by Application
2.5.1 Global Ivosidenib Sale Market Share by Application (2017-2022)
2.5.2 Global Ivosidenib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ivosidenib Sale Price by Application (2017-2022)
3 Global Ivosidenib by Company
3.1 Global Ivosidenib Breakdown Data by Company
3.1.1 Global Ivosidenib Annual Sales by Company (2020-2022)
3.1.2 Global Ivosidenib Sales Market Share by Company (2020-2022)
3.2 Global Ivosidenib Annual Revenue by Company (2020-2022)
3.2.1 Global Ivosidenib Revenue by Company (2020-2022)
3.2.2 Global Ivosidenib Revenue Market Share by Company (2020-2022)
3.3 Global Ivosidenib Sale Price by Company
3.4 Key Manufacturers Ivosidenib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ivosidenib Product Location Distribution
3.4.2 Players Ivosidenib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ivosidenib by Geographic Region
4.1 World Historic Ivosidenib Market Size by Geographic Region (2017-2022)
4.1.1 Global Ivosidenib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ivosidenib Annual Revenue by Geographic Region
4.2 World Historic Ivosidenib Market Size by Country/Region (2017-2022)
4.2.1 Global Ivosidenib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ivosidenib Annual Revenue by Country/Region
4.3 Americas Ivosidenib Sales Growth
4.4 APAC Ivosidenib Sales Growth
4.5 Europe Ivosidenib Sales Growth
4.6 Middle East & Africa Ivosidenib Sales Growth
5 Americas
5.1 Americas Ivosidenib Sales by Country
5.1.1 Americas Ivosidenib Sales by Country (2017-2022)
5.1.2 Americas Ivosidenib Revenue by Country (2017-2022)
5.2 Americas Ivosidenib Sales by Type
5.3 Americas Ivosidenib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ivosidenib Sales by Region
6.1.1 APAC Ivosidenib Sales by Region (2017-2022)
6.1.2 APAC Ivosidenib Revenue by Region (2017-2022)
6.2 APAC Ivosidenib Sales by Type
6.3 APAC Ivosidenib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ivosidenib by Country
7.1.1 Europe Ivosidenib Sales by Country (2017-2022)
7.1.2 Europe Ivosidenib Revenue by Country (2017-2022)
7.2 Europe Ivosidenib Sales by Type
7.3 Europe Ivosidenib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ivosidenib by Country
8.1.1 Middle East & Africa Ivosidenib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ivosidenib Revenue by Country (2017-2022)
8.2 Middle East & Africa Ivosidenib Sales by Type
8.3 Middle East & Africa Ivosidenib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ivosidenib
10.3 Manufacturing Process Analysis of Ivosidenib
10.4 Industry Chain Structure of Ivosidenib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ivosidenib Distributors
11.3 Ivosidenib Customer
12 World Forecast Review for Ivosidenib by Geographic Region
12.1 Global Ivosidenib Market Size Forecast by Region
12.1.1 Global Ivosidenib Forecast by Region (2023-2028)
12.1.2 Global Ivosidenib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ivosidenib Forecast by Type
12.7 Global Ivosidenib Forecast by Application
13 Key Players Analysis
13.1 Agios Pharmaceuticals
13.1.1 Agios Pharmaceuticals Company Information
13.1.2 Agios Pharmaceuticals Ivosidenib Product Offered
13.1.3 Agios Pharmaceuticals Ivosidenib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Agios Pharmaceuticals Main Business Overview
13.1.5 Agios Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Ivosidenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ivosidenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 60 Tablets
Table 4. Major Players of 30 Tablets
Table 5. Global Ivosidenib Sales by Type (2017-2022) & (K Units)
Table 6. Global Ivosidenib Sales Market Share by Type (2017-2022)
Table 7. Global Ivosidenib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Ivosidenib Revenue Market Share by Type (2017-2022)
Table 9. Global Ivosidenib Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Ivosidenib Sales by Application (2017-2022) & (K Units)
Table 11. Global Ivosidenib Sales Market Share by Application (2017-2022)
Table 12. Global Ivosidenib Revenue by Application (2017-2022)
Table 13. Global Ivosidenib Revenue Market Share by Application (2017-2022)
Table 14. Global Ivosidenib Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Ivosidenib Sales by Company (2020-2022) & (K Units)
Table 16. Global Ivosidenib Sales Market Share by Company (2020-2022)
Table 17. Global Ivosidenib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ivosidenib Revenue Market Share by Company (2020-2022)
Table 19. Global Ivosidenib Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Ivosidenib Producing Area Distribution and Sales Area
Table 21. Players Ivosidenib Products Offered
Table 22. Ivosidenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ivosidenib Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ivosidenib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ivosidenib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ivosidenib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ivosidenib Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ivosidenib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ivosidenib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ivosidenib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ivosidenib Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ivosidenib Sales Market Share by Country (2017-2022)
Table 35. Americas Ivosidenib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ivosidenib Revenue Market Share by Country (2017-2022)
Table 37. Americas Ivosidenib Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ivosidenib Sales Market Share by Type (2017-2022)
Table 39. Americas Ivosidenib Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ivosidenib Sales Market Share by Application (2017-2022)
Table 41. APAC Ivosidenib Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ivosidenib Sales Market Share by Region (2017-2022)
Table 43. APAC Ivosidenib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ivosidenib Revenue Market Share by Region (2017-2022)
Table 45. APAC Ivosidenib Sales by Type (2017-2022) & (K Units)
Table 46. APAC Ivosidenib Sales Market Share by Type (2017-2022)
Table 47. APAC Ivosidenib Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ivosidenib Sales Market Share by Application (2017-2022)
Table 49. Europe Ivosidenib Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ivosidenib Sales Market Share by Country (2017-2022)
Table 51. Europe Ivosidenib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ivosidenib Revenue Market Share by Country (2017-2022)
Table 53. Europe Ivosidenib Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ivosidenib Sales Market Share by Type (2017-2022)
Table 55. Europe Ivosidenib Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ivosidenib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ivosidenib Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ivosidenib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ivosidenib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ivosidenib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ivosidenib Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Ivosidenib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Ivosidenib Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ivosidenib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ivosidenib
Table 66. Key Market Challenges & Risks of Ivosidenib
Table 67. Key Industry Trends of Ivosidenib
Table 68. Ivosidenib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ivosidenib Distributors List
Table 71. Ivosidenib Customer List
Table 72. Global Ivosidenib Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ivosidenib Sales Market Forecast by Region
Table 74. Global Ivosidenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ivosidenib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ivosidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ivosidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ivosidenib Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ivosidenib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ivosidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ivosidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ivosidenib Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ivosidenib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ivosidenib Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Ivosidenib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Ivosidenib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Ivosidenib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Ivosidenib Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ivosidenib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ivosidenib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ivosidenib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Agios Pharmaceuticals Basic Information, Ivosidenib Manufacturing Base, Sales Area and Its Competitors
Table 93. Agios Pharmaceuticals Ivosidenib Product Offered
Table 94. Agios Pharmaceuticals Ivosidenib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Agios Pharmaceuticals Main Business
Table 96. Agios Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ivosidenib
Figure 2. Ivosidenib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ivosidenib Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ivosidenib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ivosidenib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 60 Tablets
Figure 10. Product Picture of 30 Tablets
Figure 11. Global Ivosidenib Sales Market Share by Type in 2021
Figure 12. Global Ivosidenib Revenue Market Share by Type (2017-2022)
Figure 13. Ivosidenib Consumed in Hospital
Figure 14. Global Ivosidenib Market: Hospital (2017-2022) & (K Units)
Figure 15. Ivosidenib Consumed in Pharmacy
Figure 16. Global Ivosidenib Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Ivosidenib Sales Market Share by Application (2017-2022)
Figure 18. Global Ivosidenib Revenue Market Share by Application in 2021
Figure 19. Ivosidenib Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Ivosidenib Revenue Market Share by Company in 2021
Figure 21. Global Ivosidenib Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Ivosidenib Revenue Market Share by Geographic Region in 2021
Figure 23. Global Ivosidenib Sales Market Share by Region (2017-2022)
Figure 24. Global Ivosidenib Revenue Market Share by Country/Region in 2021
Figure 25. Americas Ivosidenib Sales 2017-2022 (K Units)
Figure 26. Americas Ivosidenib Revenue 2017-2022 ($ Millions)
Figure 27. APAC Ivosidenib Sales 2017-2022 (K Units)
Figure 28. APAC Ivosidenib Revenue 2017-2022 ($ Millions)
Figure 29. Europe Ivosidenib Sales 2017-2022 (K Units)
Figure 30. Europe Ivosidenib Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Ivosidenib Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Ivosidenib Revenue 2017-2022 ($ Millions)
Figure 33. Americas Ivosidenib Sales Market Share by Country in 2021
Figure 34. Americas Ivosidenib Revenue Market Share by Country in 2021
Figure 35. United States Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Ivosidenib Sales Market Share by Region in 2021
Figure 40. APAC Ivosidenib Revenue Market Share by Regions in 2021
Figure 41. China Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Ivosidenib Sales Market Share by Country in 2021
Figure 48. Europe Ivosidenib Revenue Market Share by Country in 2021
Figure 49. Germany Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Ivosidenib Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Ivosidenib Revenue Market Share by Country in 2021
Figure 56. Egypt Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Ivosidenib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Ivosidenib in 2021
Figure 62. Manufacturing Process Analysis of Ivosidenib
Figure 63. Industry Chain Structure of Ivosidenib
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
